
Source briefing
Evaluation of the FI-Lab, a laboratory-based, automated frailty index for acute care: A multicohort study
by Hugh Logan Ellis, Peter Hanlon, Liam Dunnell, Martin Whyte, Daniel H. J. Davis, Josephine Bates, Adeel Jafri, Diana Shamsutdinova, James T. Teo, Zina Ibrahim, Kenneth Rockwood Background Laboratory-based frailty indices (FI-Lab) have shown promise in geriatric medicine…
Read →
Source briefing
Human medicines European public assessment report (EPAR): Ngenla, somatrogon, Date of authorisation: 14/02/2022, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Ngenla, somatrogon, Date of authorisation: 14/02/2022, Revision: 10, Status: Authorised
Read →
Source briefing
20th anniversary of European Medicines Agency's Patients' and Consumers' Working Party (PCWP), Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 June 2026, 13:30 (CEST) to 30 June 2026, 17:30 (CEST)
20th anniversary of European Medicines Agency's Patients' and Consumers' Working Party (PCWP), Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 June 2026, 13:30 (CEST) to 30 June 2026, 17:30 (CEST)
Read →
Source briefing
Human medicines European public assessment report (EPAR): Ranivisio, ranibizumab, Date of authorisation: 25/08/2022, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Ranivisio, ranibizumab, Date of authorisation: 25/08/2022, Revision: 8, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Orladeyo, berotralstat, Date of authorisation: 30/04/2021, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Orladeyo, berotralstat, Date of authorisation: 30/04/2021, Revision: 10, Status: Authorised
Read →
Source briefing
Ash Alizadeh on Cancer Blood Tests and Early Detection
Ash Alizadeh, MD, PhD, a Stanford hematologist-oncologist and physician-scientist, joins The Future of Medicine for a conversation about cancer blood tests, DNA, early detection, and the growing ability to find traces of cancer that traditional scans may not…
Read →
Source briefing
Will Meta settlement reduce physical, mental health risks for young users?
Experts say many of its terms may help limit use, negative social comparisons, but regulation may still be necessary
Read →
Source briefing
Antimicrobial stewardship in low- and middle-income countries: Access versus adherence
by Kiarah Shchepanik, Anthony D. Bai, Heather Wise Can improving access to antimicrobial guidelines improve prescriber adherence? In a recent study published in PLOS Medicine (the LAMPA trial), a smartphone app did not improve adherence despite enhanced access…
Read →
Source briefing
Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 21, Status: Authorised
Read →
Source briefing
Communicable disease threats report, 22 – 28 August, week 35
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22 - 28 August, and includes updates on diphtheria, Ebola, swine influenza A(H1N2), respiratory virus epidemiology, Crimean-Congo haemorrhagic fever, dengue, chikungunya virus disease, Vibrio growth,…
Read →